Triumeq

Specialty_Quantity_Limit_1804-H_HIV_Medications_P2019.pdf

PDF • 220.04 KB - June 04, 2019

HIV

abacavir/dolutegravir/lamivudine

Subject to Quantity Limits

Document Entity Terms

First Published

January 1, 2018

Last Updated

June 3, 2019